MD Anderson Cancer Center, Gynecologic Oncology Center — Texas City, Texas

MD Anderson Cancer Center, Gynecologic Oncology Center is a clinical research site located in Texas City, Texas, United States 77030.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

MD Anderson Cancer Center, Gynecologic Oncology Center has participated in 1 clinical trials.

Therapeutic areas: Ovarian Cancer, Platinum-resistant Ovarian Cancer, Primary Peritoneal Carcinoma.

Sponsors: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MD Anderson Cancer Center, Gynecologic Oncology Center?

MD Anderson Cancer Center, Gynecologic Oncology Center has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MD Anderson Cancer Center, Gynecologic Oncology Center conducted?

MD Anderson Cancer Center, Gynecologic Oncology Center has 1 clinical trials on record. Their work covers Ovarian Cancer, Platinum-resistant Ovarian Cancer, Primary Peritoneal Carcinoma.

Is MD Anderson Cancer Center, Gynecologic Oncology Center accredited by Crixeo Health?

MD Anderson Cancer Center, Gynecologic Oncology Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MD Anderson Cancer Center, Gynecologic Oncology Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.